Tools and Technologies for Cell Therapy: From Platforms to Lipid Nanoparticles

Advanced cell therapies are reshaping the future of medicine—bringing new hope to patients with hard-to-treat diseases. Yet, making these therapies accessible to more people remains a significant challenge. Complex workflows, manufacturing variability, and the need for scalable solutions demand continuous scientific and technological innovation.

In this webinar, our experts will explore how Cytiva supports next-generation therapy developers through flexible platforms and advanced delivery technologies. You’ll gain insights into emerging non-viral delivery methods, including lipid nanoparticles (LNPs), and learn how they enable efficient gene editing and transient protein expression in both T cells and hematopoietic stem cells. We’ll share data on cell viability, proliferation, and editing efficiency—comparing LNPs with traditional electroporation approaches.

Join us to discuss how bridging biological innovation and manufacturing efficiency can accelerate the development of scalable, cost-effective cell therapies. Whether you are working on today’s CAR T therapies or tomorrow’s allogeneic or gene-edited solutions, this session will highlight tools and technologies designed to help you move forward with confidence.

Click here to access the link for the meeting.